
Akso Health Group: updates and filings
Price
$1.26
November 20, 2026Market cap $911M
What Ploutos Investor adds for Akso Health
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from FY2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Jul 23, 2026Annual report (foreign company)for the period to Mar 31, 2026Form20-F
- May 13, 2026Current report (foreign company)Form6-K
- Mar 23, 2026Current report (foreign company)Form6-K
- Feb 10, 2026Current report (foreign company)Form6-K
- Aug 14, 2025Annual report (foreign company)for the period to Mar 31, 2025Form20-F
- Jul 31, 2025Notice that the annual report will be filed lateFormNT 20-F
- Jun 6, 2025FilingFormEFFECT
- Jun 5, 2025Correspondence with the SECFormCORRESP
- May 22, 2025Correspondence with the SECFormCORRESP
- May 22, 2025AMENDMENT NO. 3 TO FORM F-3 (amendment)FormF-3/A
- May 1, 2025Current report (foreign company)Form6-K
- Mar 28, 2025Current report (foreign company)Form6-K
- Jan 30, 2025Letter from the SECFormUPLOAD
- Jan 6, 2025AMENDMENT NO. 2 TO FORM F-3 (amendment)FormF-3/A
- Jan 6, 2025Correspondence with the SECFormCORRESP
- Dec 17, 2024Letter from the SECFormUPLOAD
- Nov 26, 2024AMENDMENT NO. 1 TO FORM F-3 (amendment)FormF-3/A
- Nov 26, 2024WITHDRAWAL REQUESTFormRW
- Nov 21, 2024AMENDMENT NO. 1 TO FORM F-3 (amendment)FormF-3/A
- Nov 8, 2024Current report (foreign company)Form6-K
- Sep 30, 2024Letter from the SECFormUPLOAD
- Jul 30, 2024Annual report (foreign company)for the period to Mar 31, 2024Form20-F
- Jun 28, 2024Correspondence with the SECFormCORRESP
- Jun 24, 2024FilingFormF-6 POS
- Jun 14, 2024Letter from the SECFormUPLOAD
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Jul 23, 2026 | 20-F | Annual report (foreign company)for the period to Mar 31, 2026 | Document |
| May 13, 2026 | 6-K | Current report (foreign company) | Document |
| Mar 23, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 10, 2026 | 6-K | Current report (foreign company) | Document |
| Aug 14, 2025 | 20-F | Annual report (foreign company)for the period to Mar 31, 2025 | Document |
| Jul 31, 2025 | NT 20-F | Notice that the annual report will be filed late | Document |
| Jun 6, 2025 | EFFECT | Filing | Document |
| Jun 5, 2025 | CORRESP | Correspondence with the SEC | Document |
| May 22, 2025 | CORRESP | Correspondence with the SEC | Document |
| May 22, 2025 | F-3/A | AMENDMENT NO. 3 TO FORM F-3 (amendment) | Document |
| May 1, 2025 | 6-K | Current report (foreign company) | Document |
| Mar 28, 2025 | 6-K | Current report (foreign company) | Document |
| Jan 30, 2025 | UPLOAD | Letter from the SEC | Document |
| Jan 6, 2025 | F-3/A | AMENDMENT NO. 2 TO FORM F-3 (amendment) | Document |
| Jan 6, 2025 | CORRESP | Correspondence with the SEC | Document |
| Dec 17, 2024 | UPLOAD | Letter from the SEC | Document |
| Nov 26, 2024 | F-3/A | AMENDMENT NO. 1 TO FORM F-3 (amendment) | Document |
| Nov 26, 2024 | RW | WITHDRAWAL REQUEST | Document |
| Nov 21, 2024 | F-3/A | AMENDMENT NO. 1 TO FORM F-3 (amendment) | Document |
| Nov 8, 2024 | 6-K | Current report (foreign company) | Document |
| Sep 30, 2024 | UPLOAD | Letter from the SEC | Document |
| Jul 30, 2024 | 20-F | Annual report (foreign company)for the period to Mar 31, 2024 | Document |
| Jun 28, 2024 | CORRESP | Correspondence with the SEC | Document |
| Jun 24, 2024 | F-6 POS | Filing | Document |
| Jun 14, 2024 | UPLOAD | Letter from the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 7, 2017.
The full analysis
What do Akso Health's filings show?
The filings are where every one of Akso Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.